Brickell Biotech Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Discontinues Phase 2 Study Of Imsidolimab In Acne Anaptys Bio, Inc. (NASDAQ: ANAB) said the Ph

Brickell Biotech press release (BBI): Q4 GAAP EPS of -$0.06 beats by $0.03.Revenue of $0.1M (+233.3% Y/Y) misses by $0.05M.The company reported cash and cash equivalents of…

Broadened strategic focus and expanded pipeline in immunology and inflammation following acquisition of rights to BBI-02, a potential first-in-class oral DYRK1A inhibitor, a portfolio of novel STING i

Brickell (BBI) delivered earnings and revenue surprises of 33.33% and 49.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ: IDYA ) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi Trends (NASDAQ: CTRN ) is projected to report quarterly earnings at $1.12 per share on revenue of $250.54 million. • Precision BioSciences (NASDAQ: DTIL ) is likely to report quarterly loss at $0.47 per share on revenue of $7.75 million. • SPX FLOW (NYSE: FLOW ) is estimated to report quarterly loss at $0.17 per share on revenue of $10.88 million. • Brickell Biotech (NASDAQ: BBI ) is likely to report quarterly loss at $0.08 per share on revenue of $150.00 thousand. • Imara (NASDAQ: IMRA ) is expected to report earnings for its fourth quarter. • Gamida Cell (NASDAQ: GMDA ) is estimated to report earnings for its fourth quarter. • Syros Pharmaceuticals (NASDAQ: SYRS ) is likely to report quarterly loss at $0.47 per share on revenue of $4.80 million. • Global X Guru Index ETF (NYSE: GURU ) is likely to report quarterly loss at $0.

Brickell Biotech (NASDAQ:BBI) is scheduled to announce Q4 earnings results on Tuesday, March 15th, before market open.The consensus EPS Estimate is -$0.09 (+40.0% Y/Y) and the…

Brickell Biotech, Inc. (NASDAQ:BBI) with the stream of -1.06% also noticed, India Antero Resources Corporation (NYSE:AR) encountered a rapid change of 0.34% in the last hour of Friday’s trading session. … The post Glistering Stock: Brickell Biotech, Inc. (NASDAQ:BBI), Antero Resources Corporation (NYSE:AR) appeared first on Stocks Equity .

Oncternal Therapeutics (ONCT) delivered earnings and revenue surprises of 36% and 72.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

BOULDER, Colo., March 10, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmune, inflammatory and other debilitating diseases, announced today that results from the US Phase 3 pivotal Cardigan I and Cardigan II studies of sofpironium bromide gel, 15% in primary axillary hyperhidrosis patients were selected for an oral presentation at the Late-Breaking Research session during the American Academy of Dermatology’s (AAD) 2022 Annual Meeting, which is being held from March 25-29 in Boston, MA.

BOULDER, Colo., March 08, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient l

BOULDER, Colo., March 08, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient liv

Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth quarter, compared to

Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI ) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported closing of $11 million public offering. CooTek (Cayman) Inc. (NYSE: CTK ) rose 37% to $0.4387 in pre-market trading after gaining over 36% on Tuesday. Nordstrom, Inc. (NYSE: JWN ) rose 32.1% to $25.81 in pre-market trading after reporting better-than-expected quarterly results. ECMOHO Limited (NASDAQ: MOHO ) rose 28.8% to $0.30 in pre-market trading after jumping 10% on Tuesday. Avenue Therapeutics, Inc. (NASDAQ: ATXI ) rose 26.9% to $0.77 in pre-market trading after jumping 78% on Tuesday. Avenue Therapeutics, last month, announced the outcome of the FDA meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee on IV tramadol. Brickell Biotech, Inc. (NASDAQ: BBI ) rose 26% to $0.2741 in pre-market trading after gaining around 4% on Tuesday.

Rigel (RIGL) delivered earnings and revenue surprises of 0% and 3.71%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Brickell Biotech Inc (NASDAQ: BBI ) has entered into an exclusive agreement with Carna Biosciences Inc to develop and commercialize Carna''s portfolio of oral Stimulator Interferon Genes (STING) antagonists. STING is a well-known mediator of innate immune responses. Excessive signaling through STING is linked to several diseases, ranging from autoimmune disorders, such as systemic lupus erythematosus and rheumatoid Full story available on Benzinga.com